# Miglustat in Cystic Fibrosis

> **NCT00742092** · PHASE2 · COMPLETED · sponsor: **Actelion** · enrollment: 11 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** miglustat
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00742092
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2014-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00742092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00742092, "Miglustat in Cystic Fibrosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00742092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*